Venus Remedies Q2 Results

  • BSE: 526953
  • NSE: VENUSREM
  • ISIN: INE411B01019
  • Sector: Biotechnology & Drugs
BSE
299.97.85 (2.69%)
Volume1.66 K
Updated: Mon 25 Nov, 2024 | 15:28:02
NSE
291.5-0.35 (-0.12%)
Volume22.66 K
Updated: Mon 25 Nov, 2024 | 15:29:49
Today: 288.25
299.90
52-Wk: 280.00
429.60

Q2 Results Highlights

  • Total Income
    ₹167.45 Cr.
    (54.18%)
  • Operating Profit
    ₹-1.49 Cr.
    (NA%)
  • Profit After Tax
    ₹3.51 Cr.
    (185.37%)
  • Operating Margin
    -0.89%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Venus Remedies Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 167.4595.15-%167.72-%
Selling/ General/ Admin Expenses Total 50.0532.88-%47.99-%
Depreciation/ Amortization 6.407.55-%6.44-%
Other Operating Expenses Total -0.01--%--%
Total Operating Expense 168.9492.30-%156.37-%
Operating Income -1.492.85-%11.35-%
Net Income Before Taxes 9.075.05-%14.34-%
Net Income 3.511.18-%9.94-%
Diluted Normalized EPS 2.630.88-%7.44-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts